Literature DB >> 35982917

The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda.

François Hakizayezu1, Emmanuel Biracyaza2, Hosee Niyompano3, Aline Umubyeyi1.   

Abstract

Background: By the end of 2015, epidemiological studies approximated 37 million people living with HIV (PLHIV) and 46.3% of them were initiated to antiretroviral therapies. From the 90-90-90 strategy, by 2020 at global level, 90% of all people living with HIV were expected to suppress viral load (VL). Although VL suppression is an important indicator of treatment success in PLHIV, studies on this indicator remain scarce in Rwanda where the prevalence of HIV is 3% with 9% for non-suppression. This work, thus, determined the prevalence of VL non-suppression and its associated predictors among PLHIV.
Methods: A cross-sectional study was conducted among 637 PLHIV enrolled in healthcare services between 2016 and 2017 in Nyaruguru district. Socio-demographic, treatment, clinical, immunological and VL data were extracted from medical records. Bivariate and multivariate logistic regression analyses were performed to determine associated factors with VL suppression considering 95% confidence intervals and statistical significance of p<0.005.
Results: More than half of participants were female (57.77%). The prevalence of unsuppressed HIV VL was 8.9% and 88.7% of respondents were satisfied with the service provided. Males were more likely to be unsuppressed HIV VL [aOR = 3.02; 95% CI (1.19-7.64), p = 0.02] than females. Higher likelihoods of VL non-suppression were among those with history of clinical failure [aOR = 3.14; 95% CI (1.70-14.03), p = 0.034] or history of treatment interruption [aOR = 8.29; 95% CI (2.60-26.42) p = 0.002]. Those with a bad perception toward the whole life treatment were more likely to be unsuppressed [aOR = 4.32; 95% CI (1.98-18.99), p = 0.049] than their counterparts.
Conclusion: Sex, treatment interruption, bad perception toward the whole life treatment, clinical failure and lack of confidentiality were the major predictors of being unsuppressed. More efforts on counseling HIV patients to improve their knowledge would drop levels of VL non-suppression, so improving the quality of service should be prioritized to increase suppression.
© 2022 Hakizayezu et al.

Entities:  

Keywords:  HIV/AIDS; adherence; antiretroviral; suppression; unsuppressed

Year:  2022        PMID: 35982917      PMCID: PMC9380829          DOI: 10.2147/HIV.S376053

Source DB:  PubMed          Journal:  HIV AIDS (Auckl)        ISSN: 1179-1373


  20 in total

1.  Questions and answers about defensins.

Authors:  R I Lehrer
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 2.  Core measures: implications for plastic surgery.

Authors:  James B Collins; Charles N Verheyden; Raman C Mahabir
Journal:  Plast Reconstr Surg       Date:  2013-06       Impact factor: 4.730

3.  Declaration of Helsinki and protection for vulnerable research participants--reply.

Authors:  Joseph Millum; David Wendler; Ezekiel J Emanuel
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

4.  Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco.

Authors:  Titou Hicham; Elkassimi Ilyas; Hanafi Tarik; Baba Noureddine; Boudi Omar; Frikh Rachid; Hjira Naoufal; Boui Mohammed
Journal:  Int J Mycobacteriol       Date:  2019 Apr-Jun

5.  Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.

Authors:  D Joseph Davey; Z Abrahams; M Feinberg; M Prins; C Serrao; B Medeossi; E Darkoh
Journal:  Int J STD AIDS       Date:  2018-01-16       Impact factor: 1.359

6.  Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia.

Authors:  Birhanu Waju; Lamessa Dube; Muktar Ahmed; Semira Shimeles Assefa
Journal:  HIV AIDS (Auckl)       Date:  2021-05-14

7.  Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam.

Authors:  Suresh Rangarajan; J Colby Donn; Le Truong Giang; Duc Duong Bui; Huu Hung Nguyen; Plui Broh Tou; Tran Tri Danh; Ngoc Bao Chau Tran; Duc Anh Nguyen; Bao Tram Hoang Nguyen; Vu Tuyet Nga Doan; Nhat Quang Nguyen; Van Phuoc Pham; Duc Giang Dao; Mario Chen; Yanwu Zeng; Thi Thu Van Tieu; My Hanh Tran; Thi Hoa Le; Xuan Chien Hoang; Gary West
Journal:  J Virus Erad       Date:  2016-04-01

8.  Improved life expectancy of people living with HIV: who is left behind?

Authors:  Ingrid T Katz; Brendan Maughan-Brown
Journal:  Lancet HIV       Date:  2017-05-10       Impact factor: 12.767

9.  Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.

Authors:  Patrick Owuor Mbullo; Lisa Ruth Hirschhorn; Maya Jackson-Gibson; Ashley Uzoamaka Ezema; Wicklife Orero; Irene Were; Ramael Osasogie Ohiomoba
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

10.  Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.

Authors:  Peter Cherutich; Andrea A Kim; Timothy A Kellogg; Kenneth Sherr; Anthony Waruru; Kevin M De Cock; George W Rutherford
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.